Have questions, suggestions, or concerns?

Program Directors:

Mailing Address:

Siebel Scholars Foundation
1300 Seaport Blvd., Suite 400
Redwood City, CA 94063


(650) 299-5260

2010 - Douglas Jones

A supplemental reading assignment comparing the study of water flowing through pipes to blood flowing through the blood vessels changed the course of Douglas Jones’ work.  Today, he has achieved initial success with research that could change the way cancer is identified, evaluated, and treated.

Douglas was inspired to transition from chemical engineering to bioengineering in part by an article that his fluid dynamics professor recommended.  In the final year of his doctoral research, he has engineered proteins to target the metastatic stage of cancer—in contrast to many therapies, which target the cancer itself.  These proteins could also be used to non-invasively detect cancers prior to metastasis, in turn helping to locate and determine the aggressiveness of the cancer and guide appropriate treatment strategies.

The first member of his family to earn a college degree after high school, Douglas is passionate about encouraging minority students to pursue opportunities in math and science.  As an undergraduate at the University of California, Santa Barbara, Douglas helped expand Los Ingenieros, an engineering student organization dedicated to leadership, professional development, and outreach to minority students interested in science and engineering.  Douglas worked closely with educators and schools across Southern California to recruit participants and enhance the organization’s signature science and technology fair.  Under his leadership, the organization was named UC Santa Barbara Student Organization of the Year, and the annual event now attracts more than 1,000 students with marine biology touch tanks, a physics toybox, a circuit-building workshop, and other interactive opportunities for participants to experience engineering’s real-world applications.

Prior to graduate school, Douglas worked on chemical engineering projects at Chevron and at Lawrence Livermore National Laboratory.  He hopes to establish his own lab to continue his research in therapeutic protein engineering and teach, as well.